Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ruiyi Biotechnology (Realbio Technology)

Request full access

Ruiyi Biotechnology is a national high-tech enterprise

ChinaFounded 2014Biotech & Life Sciences

About Ruiyi Biotechnology (Realbio Technology)

RealBio is a cutting-edge startup specializing in early and accurate tumor detection, with a particular focus on colorectal cancer. The company has developed a patented test called COLOWELL, which uses advanced technology to predict the risk of colorectal cancer. This test works by analyzing the methylation levels of two specific genes, SFRP2 and SDC2, found in cells shed in stool samples. By leveraging a large sample data analysis model, COLOWELL can provide highly accurate predictions, making it a valuable tool in early cancer detection.

RealBio operates in the healthcare and biotechnology market, serving a range of clients including hospitals, clinics, and diagnostic laboratories. These clients are looking for reliable and non-invasive methods to detect cancer early, which can significantly improve patient outcomes and reduce treatment costs.

The company's business model is based on selling its COLOWELL test kits to healthcare providers. These providers then use the kits to test patients and identify those at risk of colorectal cancer. RealBio generates revenue through the sale of these kits and potentially through partnerships or licensing agreements with larger medical and diagnostic companies.

RealBio's participation in events like the AACC Annual Scientific Meeting and Clinical Lab Expo highlights its commitment to staying at the forefront of clinical diagnostics and medical equipment innovation. This exposure helps the company build credibility and expand its market reach.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
17.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Hospital, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Mar 2020 $0 — Undisclosed —
SERIES A✓Equity / VC Apr 2019 $15M $60M Luxin Venture Capital · Marathon Venture Partners · Wuxi Capital —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Ruiyi Biotechnology (Realbio Technology) website traffic

Latest recorded traffic for Ruiyi Biotechnology (Realbio Technology) is 1.1K monthly website visits, down 90.8% over the last three months.

Latest monthly visits1.1K 3-month web change-90.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Ruiyi Biotechnology (Realbio Technology) in its local ecosystem

Live from Dealroom

The Ruiyi Biotechnology (Realbio Technology) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Luxin Venture Capital
  • Wuxi Capital
  • Marathon Venture Partners
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ruiyi Biotechnology (Realbio Technology) on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ruiyi Biotechnology (Realbio Technology)’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.